According to previous studies, due to its key role in metabolic and apoptotic regulation, VDAC1 is also involved in pancreatic cancer progression, is being studied as a potential anti-cancer therapeutic target15, 28. This evidence concerns the gene VDAC1 and familial pancreatic carcinoma.